Basic Research in Cardiology

, Volume 101, Issue 1, pp 53–60 | Cite as

Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia–reperfusion injury

Evidence for a role of KATP channels


Hydrogen sulfide (H2S) is a gaseous mediator, produced by the metabolic pathways that regulate tissue concentrations of sulfur–containing amino acids. Recent studies indicate that endogenous or exogenous H2S exerts physiological effects in the cardiovascular system of vertebrates, possibly through modulation of KATP channel opening. The present study was undertaken to examine the hypothesis that H2S is cytoprotective against myocardial ischemia–reperfusion injury and that this protective action is mediated by KATP opening. Rat isolated hearts were Langendorff–perfused and underwent 30 min left main coronary artery occlusion and 120 min reperfusion. The resulting injury was assessed as infarct size, determined by tetrazolium staining. Treatment of hearts with the H2S–donor, NaHS, commencing 10 min prior to the onset of coronary occlusion and maintained until 10 min reperfusion, resulted in a concentration–dependent limitation of infarct size (control, 41.0 ± 2.6% of risk zone; NaHS 0.1 μM, 33.9 ± 2.1%, [0.05 > P < 0.1]; NaHS 1 μM, 20.2 ± 2.1% [P < 0.01]). Pretreatment with the KATP channel blockers glibenclamide 10 μM or sodium 5–hydroxydecanoate (5HD) 100 μM led to abrogation of the infarct–limiting effect of NaHS 1 μM (glibenclamide + NaHS 42.5 ± 3.6%; 5HD + NaHS 44.7 ± 2.2%). No statistically significant effects of NaHS treatment on coronary flow, heart rate or left ventricular developed pressure were observed in this experimental preparation. These data provide the first evidence that exogenous H2S protects against irreversible ischemia–reperfusion injury in myocardium and support the involvement of KATP opening in the mechanism of action. Further work is required to elucidate the potential role of endogenous H2S as a cytoprotective mediator against myocardial ischemia–reperfusion injury, the mechanisms regulating its generation, and the nature of its interaction with protein targets such as the KATP channel.

Key words

hydrogen sulfide ischemia–reperfusion infarct size KATP channel 







sodium 5–hydroxydecanoate


hydrogen sulfide


ATP–dependent K+ channel


sodium hydrosulfide


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abe K, Kimura H (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16:1066–1071PubMedGoogle Scholar
  2. 2.
    Bell RM, Maddock HL, Yellon DM (2003) The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart. Cardiovasc Res 57:405–415PubMedCrossRefGoogle Scholar
  3. 3.
    Budas GR, Jovanovic S, Crawford RM, Jovanovic A (2004) Hypoxia–induced preconditioning in adult stimulated cardiomyocytes is mediated by the opening and trafficking of sarcolemmal KATP channels. FASEB J 18:1046–1048PubMedGoogle Scholar
  4. 4.
    Cheng Y, Ndsiang JF, Tang G, Cao K, Wang R (2004) Hydrogen sulfide–induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287:H2316–H2323PubMedGoogle Scholar
  5. 5.
    Das M, Parker JE, Halestrap AP (2003) Matrix volume measurements challenge the existence of diazoxide/glibenclamidesensitive KATP channels in rat mitochondria. J Physiol 547:893–902PubMedCrossRefGoogle Scholar
  6. 6.
    Dombkowski RA, Russell MJ, Olson KR (2004) Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol 286:R678–R685PubMedGoogle Scholar
  7. 7.
    Dombkowski RA, Russell MJ, Schulman AA, Doellmann MM, Olson KR (2005) Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol 288:R243–R52PubMedGoogle Scholar
  8. 8.
    D’Souza SP, Yellon DM, Martin C, Schulz R, Heusch G, Onody A, Ferdinandy P, Baxter GF (2003) B–type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 284:H1592–H1600PubMedGoogle Scholar
  9. 9.
    Fruchart JC, Nieman MC, Stroes ES, Kastelein JJ, Duriez P (2004) New risk factors for atherosclerosis and patient risk assessment. Circulation 109 (suppl):iii– 15–19CrossRefGoogle Scholar
  10. 10.
    Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, Tang C (2004) H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Comm 313:362–368PubMedCrossRefGoogle Scholar
  11. 11.
    Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J, Tang C (2004) Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Comm 318:756–763PubMedCrossRefGoogle Scholar
  12. 12.
    Gross GJ (2000) The role of mitochondrial KATP channels in cardioprotection. Basic Res Cardiol 95:280–284PubMedCrossRefGoogle Scholar
  13. 13.
    Gross GJ, Peart JN (2003) KATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 285:H921–H930PubMedGoogle Scholar
  14. 14.
    Grover GJ, Garlid KD (2000) ATP–sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cel Cardiol 32:677–695Google Scholar
  15. 15.
    Halestrap AP, Clarje SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion: a target for cardioprotection. Cardiovasc Res 61:372–385PubMedCrossRefGoogle Scholar
  16. 16.
    Hosoki R, Matsuki N, Kimura H (1997) The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237:527–531PubMedCrossRefGoogle Scholar
  17. 17.
    Integrated Risk Information System (2003) Toxicological review of hydrogen sulphide. US Environmental Protection Agency review EPA/635/R–03/005 (pdf.). www. epa. gov/iris [accessed 24 January 2005]Google Scholar
  18. 18.
    Kimura H (2002) Hydrogen sulfide as a neuromodulator. Mol Neurobiol 26:13–19PubMedGoogle Scholar
  19. 19.
    Lu Y, O’Dowd BF, Orrego H, Israel Y (1992) Cloning and nucleotide sequence of human liver cDNA encoding for cystathionine gamma–lyase. Biochem Biophys Res Commun 189:749–758PubMedCrossRefGoogle Scholar
  20. 20.
    Meier M, Janosik M, Kery V, Kraus JP, Burkhard P (2001) Structure of human cystathionine beta–synthase: a unique pyridoxal 5’–phosphate–dependent heme protein. EMBO J 20:3910–3916PubMedCrossRefGoogle Scholar
  21. 21.
    Moore PK, Bhatia M, Moochhala S (2004) Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol Sci 24:609–611Google Scholar
  22. 22.
    Quayle JM, Nelson MT, Standen NB (1997) ATP–sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77:1165–1232PubMedGoogle Scholar
  23. 23.
    Stipanuk MH (2004) Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr 24:539–577PubMedCrossRefGoogle Scholar
  24. 24.
    Stipanuk MH, Beck PW (1982) Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 206:267–277PubMedGoogle Scholar
  25. 25.
    Tang G, Wu L, Liang W, Wang R (2005) Direct stimulation of KATP channels by exogenous and endogenous hydrogen sulphide in vascular sooth muscle. Mol Pharmacol Doi:10. 1124/mol. 105. 017467 [accessed 8 November 2005]Google Scholar
  26. 26.
    Teague B, Asiedu S, Moore PK (2002) The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol 137:139–145PubMedCrossRefGoogle Scholar
  27. 27.
    Wang R (2002) Two’s company, three’s a crowd: can H2S be the third endogenous gaseous mediator? FASEB J 16:1792–1798PubMedCrossRefGoogle Scholar
  28. 28.
    Wang R (2003) The gasotransmitter role of hydrogen sulfide. Antioxid redox Signal 5:493–501PubMedCrossRefGoogle Scholar
  29. 29.
    Whiteman M, Armstrong JS, Chu SH, Jia– Ling S, Wong BS, Cheung NS, Halliwell B, Moore PK (2004) The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite "scavenger"? J Neurochem 90:765–768PubMedCrossRefGoogle Scholar
  30. 30.
    Whiteman M, Cheung N S, Zhu Y–Z, Chu S H, Siau JL, Wong BS, Armstrong JS, Moore PK (2005) Hydrogen sulphide: a novel inhibitor of hypochlorous acidmediated oxidative damage in the brain? Biochem Biophys Res Commun 326:794–798PubMedCrossRefGoogle Scholar
  31. 31.
    Zhao W, Wang R (2002) H2S–induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283:H474–H480PubMedGoogle Scholar
  32. 32.
    Zhao W, Zhang J, Lu Y, Wang R (2001) The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20:6008–6016PubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  1. 1.Department of Basic SciencesThe Royal Veterinary College, University of LondonLondon NW1 0TUUK
  2. 2.Department of Medical PhysiologyUniversity of TromsøNorway

Personalised recommendations